Predicting early cancer spread after radiation for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at past patient information to find clues that might predict whether cervical cancer will spread after radiation therapy. By joining, you help doctors learn how to better identify who might need extra monitoring or treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have cervical cancer confirmed by a biopsy.
- You must be getting or have gotten radiation therapy as your main treatment.
- You cannot have had surgery to remove the cancer.
- You cannot have a history of any other cancer.
- You cannot have had any surgery in the pelvic area.
- You must have complete medical records and follow-up for at least one year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at MRI scans from people with cervical cancer to predict how well they might do with radiotherapy. It aims to help doctors better tailor treatments and improve survival.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This study looks at how cervical cancer and radiation therapy affect the body. It aims to understand why side effects happen, which could lead to better treatment in the future.
This trial tests a special type of radiation that is given in small, spaced-out beams to treat gynecologic cancers (like cervical or uterine cancer). It is for patients who cannot get standard internal radiation (brachytherapy) because of unusual anatomy, large tumors, a narrow vagina, or anesthesia risks.
This trial tests whether radiation therapy after surgery is safe and effective for early-stage endometrial cancer. It is designed for patients with certain molecular subtypes and who have not had chemotherapy.
This study checks if a simple scoring tool can predict whether cervical cancer has spread to the vagina, using your MRI and blood test results before surgery. If you're having surgery for early-stage cervical cancer, this could help your doctor plan better.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.